<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02377024</url>
  </required_header>
  <id_info>
    <org_study_id>EBI_CT_TF</org_study_id>
    <nct_id>NCT02377024</nct_id>
  </id_info>
  <brief_title>Effects of Tremella Fuciformis on Improvement in Cognitive-Bio-Markers of Cognitive Functions</brief_title>
  <official_title>Effects of Tremella Fuciformis on Improvement in Cognitive-Bio-Markers of Cognitive Functions in Healthy Adults With Subjective Cognitive Impairment: An 8-Week Prospective Randomized Double-Blind Placebo-Controlled Trial With Multimodal Neuroimaging and Neurocognitive Assessments</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ewha Womans University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ewha Womans University</source>
  <brief_summary>
    <textblock>
      The objective of this study is to demonstrate the cognitive enhancement effect and safety of&#xD;
      Tremella Fuciformis, using the cognitive and clinical indicators (e.g. memory, attention, and&#xD;
      psychomotor speed) and the latest brain imaging methods for healthy adults suffering&#xD;
      subjective cognitive impairment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes from baseline in neurocognitive function (neurocognitive test batteries such as CANTAB)</measure>
    <time_frame>baseline, 8th week</time_frame>
    <description>Scores from neurocognitive test batteries such as CANTAB</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes from baseline in brain structure analyzed using the computational approach</measure>
    <time_frame>baseline, 8th week</time_frame>
    <description>Morphometric analysis of brain structures in magnetic resonance imaging</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes from baseline in brain function analyzed using the computational approach (Blood oxygenation level dependent (BOLD) signal intensity)</measure>
    <time_frame>baseline, 8 week</time_frame>
    <description>Blood oxygenation level dependent (BOLD) signal intensity and their connectivity assessed using functional magnetic resonance imaging scans</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes from baseline in brain biochemical metabolism analyzed using the computational approach (Brain metabolite concentrations assessed using magnetic resonance spectroscopy)</measure>
    <time_frame>baseline, 8th week</time_frame>
    <description>Brain metabolite concentrations assessed using magnetic resonance spectroscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Subjective Memory Complaints Questionnaire scores at 8th weeks</measure>
    <time_frame>baseline, 8th week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with adverse events</measure>
    <time_frame>4th week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with adverse events</measure>
    <time_frame>8th week</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Healthy Adults With Subjective Memory Complaints</condition>
  <arm_group>
    <arm_group_label>TF 600mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TF 600mg/day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TF 1200mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TF 1200mg/day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>TF 600mg</intervention_name>
    <arm_group_label>TF 600mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>TF 1200mg</intervention_name>
    <arm_group_label>TF 1200mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 40 and 65 years old&#xD;
&#xD;
          -  Global Deterioration Scale score (GDS) of 2&#xD;
&#xD;
          -  High school or higher levels of education.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current pregnancy or breast-feeding&#xD;
&#xD;
          -  Evidence of neurologic or medical conditions&#xD;
&#xD;
          -  Axis I diagnosis when assessed by the board certified psychiatrist using the&#xD;
             Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental&#xD;
             Disorder, 4th edition (DSM-IV)(SCID-IV)&#xD;
&#xD;
          -  Mini-mental status examination score of 24 or less&#xD;
&#xD;
          -  Clinical Dementia Rating score of 0.5 or more suggesting cognitive impairment beyond&#xD;
             self-perceived subjective deficits&#xD;
&#xD;
          -  Intelligence quotient less than 70&#xD;
&#xD;
          -  Contraindications to magnetic resonance imaging (MRI)&#xD;
&#xD;
          -  Use of psychotropics in last 3 months&#xD;
&#xD;
          -  Use of oral contraceptive medication&#xD;
&#xD;
          -  Participation in other clinical trials during the study period that might affect the&#xD;
             outcome of the present study&#xD;
&#xD;
          -  Allergic adverse reactions to mushrooms&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ewha Womans University</name>
      <address>
        <city>Seoul</city>
        <zip>120-750</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <study_first_submitted>February 26, 2015</study_first_submitted>
  <study_first_submitted_qc>March 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2015</study_first_posted>
  <last_update_submitted>June 30, 2015</last_update_submitted>
  <last_update_submitted_qc>June 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ewha Womans University</investigator_affiliation>
    <investigator_full_name>In Kyoon Lyoo</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

